EDBT 2026 Demo / reviewers in the wild / expert
Andrew Magnuson
dblp:408/1101
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2025
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% | |
| Artificial intelligence
1 paper |
Vision and language · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Computer vision › Vision and language
multimodal reasoning |
0.9 | 1 | 2025 | BioReason: Incentivizing Multimodal Biological Reasoning within a DNA-LLM Model · NeurIPS 2025 |
Bioinformatics and computational biology › sequence analysis
genomic sequence analysis |
0.9 | 1 | 2025 | BioReason: Incentivizing Multimodal Biological Reasoning within a DNA-LLM Model · NeurIPS 2025 |
Bioinformatics and computational biology › statistical genetics
variant effect prediction |
0.9 | 1 | 2025 | BioReason: Incentivizing Multimodal Biological Reasoning within a DNA-LLM Model · NeurIPS 2025 |
Methods — techniques the papers use, named apart from their topics
supervised fine-tuning · 1.7reinforcement learning · 1.7DNA foundation model · 1.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | BioReason: Incentivizing Multimodal Biological Reasoning within a DNA-LLM ModelabstractUnlocking deep and interpretable biological reasoning from complex genomic data remains a major AI challenge limiting scientific progress. While current DNA foundation models excel at representing sequences, they struggle with multi-step reasoning and lack transparent, biologically meaningful explanations. BioReason addresses this by tightly integrating a DNA foundation model with a large language model (LLM), enabling the LLM to directly interpret and reason over genomic information. Through supervised fine-tuning and reinforcement learning, BioReason learns to produce logical, biologically coherent deductions. It achieves major performance gains, boosting KEGG-based disease pathway prediction accuracy from 86% to 98% and improving variant effect prediction by an average of 15% over strong baselines. BioReason can reason over unseen biological entities and explain its decisions step by step, offering a transformative framework for interpretable, mechanistic AI in biology. All data, code, and checkpoints are available at [https://github.com/bowang-lab/BioReason](https://github.com/bowang-lab/BioReason). Adibvafa Fallahpour, Andrew Magnuson, Purav Gupta, Shihao Ma, Jack Naimer, Arnav Shah, Haonan Duan 0002, Omar Ibrahim, Hani Goodarzi, Chris J. Maddison, Bo Wang 0044 |
NeurIPS | 2 |